White Paper

Benefiting From Bedside Specimen Labeling

Source: Zebra Technologies

Labeling blood and other samples at the time they are collected improves patient safety and helps prevent a host of problems related to misidentification — including many of the estimated 160,900 adverse events that occur in U.S. hospitals annually because of sample identification errors. There is a strong and growing body of evidence within medical literature that creating specimen identification labels on demand at the patient bedside with a mobile printer can significantly reduce errors. The Joint Commission's National Patient Safety Goals (NPSG) for 2010 advocate the use of two patient-specific identifiers, such as name and birthdate, whenever taking blood or other samples from a patient, and to label the sample collection container in the presence of the patient. Producing specimen labels at the patient bedside and encoding patient identification in a bar code satisfies both The Joint Commission's NPSG and Health Insurance Portability and Accountability Act (HIPAA) requirements. This white paper explains the point-of-care specimen labeling process, documents its benefits, outlines equipment and IT requirements, and provides tips for successful implementation.

access the White Paper!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Health IT Outcomes? Subscribe today.

Subscribe to Health IT Outcomes X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Health IT Outcomes